Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continued darunavir/ritonavir treatment in children and adolescents with HIV-1
RBR-2wjncpCompleted
- Sponsor
- Hospital Geral de Nova Iguaçu
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of darunavir and ritonavir in Human immunodeficiency virus infection type 1, sponsored by Hospital Geral de Nova Iguaçu. Started Oct 2010; status: completed.
02
Drugs
darunavirritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on RBR-2wjncp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2wjncp.